Date: ClinicalTrials.gov processed this data on October 25, 2016

URL: https://clinicaltrials.gov/show/NCT00000211

Org Study Id: NIDA-06116-2

NCT ID: NCT00000211

Title: Treatment Efficacy for Drug Abuse and AIDS Prevention - 2

Official Title: Treatment Efficacy for Drug Abuse and AIDS Prevention

Summary: 
      The purpose of this study is to assess the safety and effectiveness of buprenorphine for
      treatment of concurrent intravenous heroin and cocaine dependence.
    

Overall Status: Completed

Phase: Phase 2

Gender: Male

Minimum Age: 26

Maximum Age: 41

Healthy Volunteers: No

